The Science of The Total Environment,
Journal Year:
2021,
Volume and Issue:
816, P. 151654 - 151654
Published: Nov. 14, 2021
A
rich
body
of
literature
indicates
that
environmental
factors
interact
with
the
human
microbiome
and
influence
its
composition
functions
contributing
to
pathogenesis
diseases
in
distal
sites
body.
This
systematic
review
examines
scientific
evidence
on
effect
toxicants,
air
pollutants
endocrine
disruptors
(EDCs),
compositional
diversity
microbiota.
Articles
from
PubMed,
Embase,
WoS
Google
Scholar
where
included
if
they
focused
populations
or
SHIME®
model,
assessed
effects
EDCs
microbiome.
Non-human
studies,
not
written
English
displaying
original
research
were
excluded.
The
Newcastle-Ottawa
Scale
was
used
assess
quality
individual
studies.
Results
extracted
presented
tables.
31
studies
selected,
including
24
related
pollutants,
5
EDCs,
2
EDC
using
model.
19
focussed
respiratory
system
(19),
gut
(8),
skin
(2),
vaginal
(1)
mammary
microbiomes.
No
sufficient
number
are
available
observe
a
consistent
trend
for
most
microbiota,
except
streptococcus
veillionellales
which
9
out
10,
3
4
suggest
an
increase
abundance
exposure
pollution.
limitation
reviewed
is
scarcity
existing
assessing
microbiomes
systems.
Growing
suggests
contaminants
could
change
resident
e.g.
upper
lower
respiratory,
gastrointestinal,
female
reproductive
system.
Microbial
dysbiosis
might
lead
colonization
pathogens
outgrowth
pathobionts
facilitating
infectious
diseases.
It
also
prime
metabolic
dysfunctions
disrupting
production
beneficial
metabolites.
Further
should
elucidate
role
development
dysregulation
microbiota-related
immunological
processes.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: Jan. 16, 2023
Abstract
Microorganisms,
including
bacteria,
viruses,
fungi,
and
other
eukaryotes,
play
critical
roles
in
human
health.
An
altered
microbiome
can
be
associated
with
complex
diseases.
Intratumoral
microbial
components
are
found
multiple
tumor
tissues
closely
correlated
cancer
initiation
development
therapy
efficacy.
The
intratumoral
microbiota
may
contribute
to
promotion
of
the
progression
cancers
by
DNA
mutations,
activating
carcinogenic
pathways,
promoting
chronic
inflammation,
complement
system,
initiating
metastasis.
Moreover,
not
only
enhance
antitumor
immunity
via
mechanisms
STING
signaling
activation,
T
NK
cell
TLS
production,
microbiota-derived
antigen
presenting,
but
also
decrease
immune
responses
promote
through
pathways
upregulation
ROS,
an
anti-inflammatory
environment,
inactivation,
immunosuppression.
effect
on
is
dependent
composition,
crosstalk
between
cancer,
status
cancers.
regulate
physiology
response
different
β-catenin,
TLR,
ERK,
NF-κB,
STING,
among
others.
These
viewpoints
help
identify
as
diagnosis
or
prognosis
evaluation
cancers,
new
therapeutic
strategy
potential
targets
for
therapy.
Cells,
Journal Year:
2019,
Volume and Issue:
8(4), P. 293 - 293
Published: March 29, 2019
Breast
cancer
is
a
leading
cause
of
death
among
women
worldwide.
Dysbiosis,
an
aberrant
composition
the
microbiome,
characterizes
breast
cancer.
In
this
review
we
discuss
changes
to
metabolism
cells,
as
well
and
gut
microbiome
in
The
role
unresolved,
nevertheless
it
seems
that
does
have
pathology
disease.
secretes
bioactive
metabolites
(reactivated
estrogens,
short
chain
fatty
acids,
amino
acid
metabolites,
or
secondary
bile
acids)
modulate
We
highlight
bacterial
species
taxonomical
units
generate
these
show
their
mode
action,
how
affect
mitochondrial
other
molecular
events
These
resemble
human
hormones,
they
are
produced
"gland"
(in
case,
microbiome)
subsequently
transferred
distant
sites
action
through
circulation.
appear
be
important
constituents
tumor
microenvironment.
Finally,
dysbiosis
interferes
with
treatment
interfering
chemotherapeutic
drug
availability.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: May 20, 2024
Abstract
Tumor
biomarkers,
the
substances
which
are
produced
by
tumors
or
body’s
responses
to
during
tumorigenesis
and
progression,
have
been
demonstrated
possess
critical
encouraging
value
in
screening
early
diagnosis,
prognosis
prediction,
recurrence
detection,
therapeutic
efficacy
monitoring
of
cancers.
Over
past
decades,
continuous
progress
has
made
exploring
discovering
novel,
sensitive,
specific,
accurate
tumor
significantly
promoted
personalized
medicine
improved
outcomes
cancer
patients,
especially
advances
molecular
biology
technologies
developed
for
detection
biomarkers.
Herein,
we
summarize
discovery
development
including
history
conventional
innovative
used
biomarker
classification
biomarkers
based
on
tissue
origins,
application
clinical
management.
In
particular,
highlight
recent
advancements
biomarker-based
anticancer-targeted
therapies
emerging
as
breakthroughs
promising
strategies.
We
also
discuss
limitations
challenges
that
need
be
addressed
provide
insights
perspectives
turn
into
opportunities
this
field.
Collectively,
multiple
emphasized
review
may
guidance
precision
medicine,
broaden
horizons
future
research
directions,
expedite
patients
according
their
rather
than
organs
origin.
Cellular and Molecular Life Sciences,
Journal Year:
2020,
Volume and Issue:
77(14), P. 2739 - 2749
Published: Jan. 23, 2020
Abstract
Like
other
body
districts,
lungs
present
a
complex
bacteria
community.
An
emerging
function
of
lung
microbiota
is
to
promote
and
maintain
state
immune
tolerance,
prevent
uncontrolled
not
desirable
inflammatory
response
caused
by
inhalation
harmless
environmental
stimuli.
This
effect
mediated
continuous
dialog
between
commensal
cells
resident
in
lungs,
which
express
repertoire
sensors
able
detect
microorganisms.
The
same
receptors
are
also
involved
the
recognition
pathogens
mounting
proper
response.
Due
its
important
role
preserving
homeostasis,
can
be
considered
mirror
health
status.
Indeed,
several
studies
indicate
that
bacterial
composition
drastically
changes
during
occurrence
pulmonary
pathologies,
such
as
cancer,
available
data
suggest
modifications
part
etiology
tumors
influence
their
progression
therapy.
These
results
provide
scientific
rationale
analyze
biomarker
for
cancer
consider
new
potential
target
therapeutic
intervention
reprogram
antitumor
microenvironment.
In
review,
we
discussed
about
physiology
summarized
most
relevant
relationship
cancer.
Journal of Cancer Research and Clinical Oncology,
Journal Year:
2021,
Volume and Issue:
147(8), P. 2177 - 2186
Published: May 20, 2021
Abstract
Background
Lung
cancer
is
the
leading
cause
of
cancer-related
deaths
worldwide
(Ferlay
et
al.,
Int
J
Cancer
136:E359–386,
2015).
In
addition,
lung
associated
with
highest
mortality
among
all
types
(Wu
Exp
Ther
Med
16:3004–3010,
2018).
Previous
studies
report
that
microbiota
play
an
important
role
in
cancer.
Notably,
changes
and
gut
microbiota,
are
progression
Several
microbiome
promote
initiation
development
by
modulating
metabolic
pathways,
inhibiting
function
immune
cells,
producing
pro-inflammatory
factors.
some
factors
such
as
dysbiosis,
affect
production
bacteriotoxins,
genotoxicity
virulence
effect,
therefore,
they
a
key
progression.
These
findings
imply
potential
markers
targets
for
However,
has
not
been
fully
explored.
Purpose
The
aim
this
study
was
to
systemically
review
recent
research
on
relationship
we
explored
gut–lung
axis
mechanisms
Conclusion
Pulmonary
intestinal
flora
influence
occurrence,
development,
treatment
prognosis
cancer,
will
provide
novel
strategies
prevention,
diagnosis,
Antibiotics,
Journal Year:
2021,
Volume and Issue:
10(4), P. 401 - 401
Published: April 7, 2021
Antibiotics
are
considered
as
a
cornerstone
of
modern
medicine
and
their
discovery
offers
the
resolution
to
infectious
diseases
problem.
However,
excessive
use
antibiotics
worldwide
has
generated
critical
public
health
issue
bacterial
resistance
correlated
with
inefficiency
is
still
unsolved.
Finding
novel
therapeutic
approaches
overcome
imperative,
natural
compounds
antibacterial
effects
could
be
promising
option.
The
role
played
by
in
tumorigenesis
interrelation
microbiota
debatable
far
from
being
elucidated.
Thus,
present
manuscript
global
perspective
on
terms
evolution
historical
an
emphasis
main
classes
adverse
effects.
It
also
highlights
connection
between
microbiota,
focusing
dual
tumorigenesis.
In
addition,
using
properties
potential
alternatives
for
classical
antibiotic
therapy
discussed.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Jan. 17, 2024
The
lungs
were
long
thought
to
be
sterile
until
technical
advances
uncovered
the
presence
of
lung
microbial
community.
microbiome
healthy
is
mainly
derived
from
upper
respiratory
tract
(URT)
but
also
has
its
own
characteristic
flora.
selection
mechanisms
in
lung,
including
clearance
by
coughing,
pulmonary
macrophages,
oscillation
cilia,
and
bacterial
inhibition
alveolar
surfactant,
keep
transient
mobile,
which
different
other
organs.
bacteriome
been
intensively
studied
recently,
relatively
little
research
focused
on
mycobiome
virome.
This
up-to-date
review
retrospectively
summarizes
microbiome's
history,
composition,
function.
We
focus
interaction
with
oropharynx
gut
emphasize
role
it
plays
innate
adaptive
immune
responses.
More
importantly,
we
multiple
diseases,
asthma,
chronic
obstructive
disease
(COPD),
fibrosis,
bronchiectasis,
pneumonia.
impact
coronavirus
2019
(COVID-19)
cancer
comprehensively
studied.
Furthermore,
summarizing
therapeutic
potential
diseases
examining
shortcomings
field,
propose
an
outlook
direction
research.
Biomedicine & Pharmacotherapy,
Journal Year:
2022,
Volume and Issue:
155, P. 113810 - 113810
Published: Oct. 8, 2022
The
human
gut
microbiota
is
a
complex
ecosystem
involved
in
the
metabolism,
immunity,
and
health
of
host.
microbiome
plays
key
role
development
host's
innate
adaptive
immune
system,
while
system
orchestrates
maintenance
host-microbe
symbiosis.
Lung
diseases
are
usually
accompanied
by
dysbiosis
intestinal
flora
an
immune-inflammatory
response.
its
metabolites
directly
or
indirectly
regulation
host
lung
disease.
However,
exact
mechanism
action
gut-lung
axis
crosstalk
remains
unclear.
This
review
aimed
to
summarize
latest
advances
their
typical
diseases,
such
as
pulmonary
hypertension,
COPD,
cancer.
Especially
COVID-19,
problem
troubling
world,
also
discussed
it.
Moreover,
it
concentrated
on
mechanisms
between
identified
specific
link
among
microbiota,
metabolites,
regulation,
which
could
be
used
breakthrough
find
new
targets
for
some
without
therapeutic
drugs
clinic.
It
tool
"drug-bacterial
interaction"
potential
applications
would
provide
clear
direction
future
research
propose
strategy
targeting